NEW BRUNSWICK, N.J., Feb. 27, 2021 /PRNewswire/ -- Johnson & Johnson (NYSE: JNJ) (the Company) today announced that the U.S. Food and Drug Administration (FDA) has issued Emergency Use Authorization (EUA) for its single-dose COVID-19 vaccine, developed by the Janssen Pharmaceutical...
from PR Newswire: https://ift.tt/30aCB4F
No comments:
Post a Comment